text.skipToContent text.skipToNavigation
Customer Notice (15 August 2025)
Due to anticipated high temperatures this weekend, we are unable to ship pharmaceutical orders. Any pharmaceutical orders placed today will ship early next week.
  • Cross.svg
    Extensive product ranges
Calling 01685 846666

Menquadfi meningococcal (group A,C,W,Y) conjugate vaccine 0.5ml solution for injection POM X 1

ID:J1509 , 4195368
Pharmaceutical Product
Order from supplier within 7 working days.

Important Notice: Pharma products are sold and shipped exclusively to registered medical professionals at verified medical premises. 

Non-approved buyers: Complete our Online POM Form, and we will notify you once your account is Pharma approved.


What is Medquadfi?:
 
MenQuadfiTM is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W and Y.

 

What is Menquafi used for?:

 

MenQuadfi is designed to help protect individuals aged 12 months and older against IMD caused by serogroups A, C, W and Y. It is the only MenACWY conjugate vaccine in Europe available in a fully liquid formulation.9,10 This can potentially save time and reduce reconstitution errors.

 

MenQuadfi uses a tetanus toxoid carrier protein, which is able to impact the T-cell dependent immune system.

 

In clinical trials, the safety of MenQuadfi was shown to be similar to comparator vaccines.

 

A MenACWY certificate will be provided on ordering MenQuadfi.


Neisseria meningitidis bacteria (also called meningococci) can be passed from person to person and can cause serious and sometimes life-threatening infections, such as:


• Meningitis – an inflammation of the tissues that surround the brain and spinal cord;
• Septicemia – an infection of the blood 

 

Patient info leaflet link:

 

pil.12818.pdf

Specs
Downloads